HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ping Xu Selected Research

Satellite RNA (Satellite RNAs)

8/2012Genetic loci controlling lethal cell death in tomato caused by viral satellite RNA infection.
12/2007Regulation of a virus-induced lethal disease in tomato revealed by LongSAGE analysis.
6/2003In spite of induced multiple defense responses, tomato plants infected with Cucumber mosaic virus and D satellite RNA succumb to systemic necrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ping Xu Research Topics

Disease

142Neoplasms (Cancer)
10/2022 - 01/2002
36Breast Neoplasms (Breast Cancer)
07/2021 - 09/2007
31Neoplasm Metastasis (Metastasis)
01/2022 - 04/2004
30Inflammation (Inflammations)
08/2022 - 03/2004
29Infections
04/2022 - 06/2003
20Hypoxia (Hypoxemia)
11/2022 - 08/2002
17Hepatocellular Carcinoma (Hepatoma)
08/2022 - 03/2008
17Carcinogenesis
01/2021 - 03/2003
14Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2022 - 09/2007
13Lung Neoplasms (Lung Cancer)
01/2021 - 04/2009
12Insulin Resistance
10/2021 - 08/2006
11Pancreatitis
06/2022 - 04/2007
11Wounds and Injuries (Trauma)
01/2022 - 04/2007
11Carcinoma (Carcinomatosis)
08/2021 - 04/2004
10Hypertension (High Blood Pressure)
01/2022 - 01/2009
9Adenocarcinoma of Lung
10/2022 - 08/2010
9Hyperglycemia
06/2021 - 03/2010
9Endocarditis
01/2021 - 04/2007
8Alzheimer Disease (Alzheimer's Disease)
02/2022 - 03/2011
8Necrosis
02/2022 - 06/2003
8Body Weight (Weight, Body)
08/2021 - 08/2006
8Liver Diseases (Liver Disease)
08/2021 - 02/2005
8Thrombosis (Thrombus)
03/2019 - 03/2011
7Non-alcoholic Fatty Liver Disease
08/2022 - 08/2006
7Obesity
08/2022 - 07/2006
7Fibrosis (Cirrhosis)
12/2021 - 01/2016
7Stomach Neoplasms (Stomach Cancer)
12/2021 - 03/2008
7Melanoma (Melanoma, Malignant)
07/2021 - 06/2008
7Type 2 Diabetes Mellitus (MODY)
07/2021 - 01/2015
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2021 - 04/2017
7Pain (Aches)
07/2021 - 09/2005
7Hyperlipidemias (Hyperlipidemia)
04/2021 - 11/2008
7Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 10/2013
6Virus Diseases (Viral Diseases)
05/2022 - 01/2008
6Disease Progression
01/2022 - 04/2006
6Endometriosis
05/2021 - 11/2015
6Prostatic Neoplasms (Prostate Cancer)
04/2021 - 01/2007
6Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 06/2003
6Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 02/2005
6BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021 - 09/2015
5Pre-Eclampsia (Preeclampsia)
01/2022 - 01/2018
5Chronic Hepatitis B
01/2022 - 12/2007
5COVID-19
01/2022 - 01/2020
5Hemorrhage
08/2021 - 04/2007
5Dyslipidemias (Dyslipidemia)
06/2021 - 11/2016
5Schizophrenia (Dementia Praecox)
01/2021 - 08/2012
5Sepsis (Septicemia)
06/2020 - 04/2012

Drug/Important Bio-Agent (IBA)

82Proteins (Proteins, Gene)FDA Link
08/2022 - 01/2002
45Pharmaceutical PreparationsIBA
10/2022 - 03/2004
28Biomarkers (Surrogate Marker)IBA
02/2022 - 01/2008
21Glucose (Dextrose)FDA LinkGeneric
01/2022 - 09/2007
20Messenger RNA (mRNA)IBA
01/2021 - 08/2002
17Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 01/2002
16TeaIBA
08/2022 - 05/2006
15Long Noncoding RNAIBA
01/2022 - 01/2015
13LipidsIBA
08/2022 - 10/2007
13CytokinesIBA
06/2022 - 05/2006
12AntioxidantsIBA
10/2021 - 01/2008
11Biological ProductsIBA
03/2022 - 11/2013
11AutoantibodiesIBA
01/2022 - 09/2007
11Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2021 - 04/2007
10MicroRNAs (MicroRNA)IBA
01/2022 - 01/2013
10Therapeutic UsesIBA
01/2022 - 03/2004
10VaccinesIBA
01/2021 - 11/2011
9DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2002
9Indicators and Reagents (Reagents)IBA
01/2022 - 09/2007
9ProteomeIBA
01/2022 - 01/2013
9Tyrosine Kinase InhibitorsIBA
01/2021 - 05/2013
8EnzymesIBA
01/2022 - 03/2003
8Insulin (Novolin)FDA Link
01/2022 - 08/2006
8LigandsIBA
01/2021 - 04/2007
8AntigensIBA
11/2020 - 11/2011
8PolyphenolsIBA
04/2020 - 05/2006
7Phosphotransferases (Kinase)IBA
05/2022 - 05/2005
7C-PeptideIBA
10/2021 - 10/2012
7epigallocatechin gallate (epigallocatechin-3-gallate)IBA
07/2021 - 09/2013
7RNA (Ribonucleic Acid)IBA
05/2021 - 06/2003
7AntibodiesIBA
01/2020 - 12/2010
7Reactive Oxygen Species (Oxygen Radicals)IBA
10/2018 - 02/2005
6CollagenIBA
10/2022 - 05/2006
6Proteasome Endopeptidase Complex (Proteasome)IBA
01/2022 - 03/2008
6Small Interfering RNA (siRNA)IBA
01/2022 - 07/2010
6Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2022 - 01/2012
6Triglycerides (Triacylglycerol)IBA
11/2021 - 10/2013
6IronIBA
05/2020 - 06/2016
6Sunitinib (Sutent)FDA Link
11/2019 - 05/2013
6Bevacizumab (Avastin)FDA Link
01/2019 - 08/2013
6pazopanibFDA Link
11/2018 - 04/2010
6A-Form DNA (A-DNA)IBA
01/2018 - 09/2015
6Pioglitazone (Actos)FDA Link
02/2016 - 08/2006
6Topotecan (Hycamtin)FDA LinkGeneric
12/2015 - 04/2010
5Cisplatin (Platino)FDA LinkGeneric
10/2022 - 12/2017
5Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 09/2008
5Circular RNAIBA
01/2022 - 01/2019
5Peptides (Polypeptides)IBA
01/2022 - 01/2011

Therapy/Procedure

65Therapeutics
11/2022 - 02/2005
38Drug Therapy (Chemotherapy)
01/2022 - 04/2007
10Immunotherapy
03/2022 - 01/2016
7Transplantation
10/2018 - 02/2005
5Aftercare (After-Treatment)
09/2022 - 07/2008